US.DXCM · Dexcom

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.555376095985233,
        "turnoverUsdM": 289.54292488,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DXCM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 82.25,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.1,
      "take_profit_price": 91.0989,
      "target_multiplier": 1.9,
      "technical_strength": 1.58,
      "take_profit_percent": 5.1
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.110752191970466,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 62.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 87.37,
    "ma50": 85.3324,
    "close": 86.68,
    "prevClose": 86.62,
    "avgVolume20": 4048303,
    "volumeRatio": 0.83,
    "changePercent": 0.07
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.02792418974991584,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.8332957476637846,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.9723276080159903,
      "volat_points": 0,
      "day_range_pct": 0.02388094139363183,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 62.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 92,
        "contribution": 4.6
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 11,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 73.33,
        "contribution": 11
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 17.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58,
        "contribution": 17.4
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.2,
    "details": [
      "基本面分析總分: 4.6/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 11/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 17.4/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.6,
      "資金流": 12.4,
      "市場環境": 11,
      "情緒分析": 4,
      "技術信號": 17.4,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 289.54292488,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 4,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DXCM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 721.8794973000001,
                "ma50": 713.4775976199999,
                "name": "QQQ",
                "close": 736.53003,
                "points": 2
              },
              "spy": {
                "ma20": 765.1634973000002,
                "ma50": 762.0121981799997,
                "name": "SPY",
                "close": 765.60999,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.555376095985233,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142389564,
                "url": "https://finnhub.io/api/news?id=ab4f9e99bbbeb3352d6984d2da00ffaa897b44bbcdf67afb376dbf86253e3dd1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom shares have delivered a mixed ride in recent years, and that uneven path raises a simple question for anyone looking at the chart today. Is the current US$87.47 price adequately supported by the cash the business is expected to generate over time? Over the past 5 years the stock has declined 36.0%, which puts the focus squarely on whether the cash flow story still lines up with the share price. The recent move to expand Jereme Sylvain’s remit to Chief Operating Officer as well as...",
                "category": "company",
                "datetime": 1790295609,
                "headline": "DexCom (DXCM) Stock Looks Cheap Based On Future Cash Flow"
              },
              {
                "id": 142370918,
                "url": "https://finnhub.io/api/news?id=7e80c34757dfb5e8e97506f9fb195de5bb917984d87162696be91d6a79a644bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (DXCM) just reshuffled its leadership team, with longtime finance chief Jereme Sylvain stepping into a combined EVP and Chief Operating Officer role that now includes responsibility for global operations and quality. Recent boardroom moves at DexCom have arrived at a time when the 90-day share price return of 27.79% and year-to-date gain of 31.85% point to building momentum. However, the 1-year total shareholder return of 29.97% contrasts with a weaker 3-year record and a deeper 5-year...",
                "category": "company",
                "datetime": 1790224168,
                "headline": "Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?"
              },
              {
                "id": 142366064,
                "url": "https://finnhub.io/api/news?id=a735547d4009b8a6a2ff1c97ea29d07de4f3eb90a08524cdb3ae4c0418045a0a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to governance. The leadership shift, including Sylvain's promotion and Boehnlein's board appointment, deserves weighing alongside DexCom's broader fundamentals and risks. Take a look at 3 other big wins we have identified for DexCom. For readers looking to...",
                "category": "company",
                "datetime": 1790201622,
                "headline": "DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer"
              },
              {
                "id": 142025511,
                "url": "https://finnhub.io/api/news?id=5e26d4769528832e8d6c467dd3c154dedeb94018b2b6266fcf8edaa9128328e5",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DXCM",
                "summary": "DexCom, Inc. (DXCM) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsJereme Sylvain - Executive VP, CFO &...",
                "category": "company",
                "datetime": 1788952625,
                "headline": "DexCom, Inc. (DXCM) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141953963,
                "url": "https://finnhub.io/api/news?id=40add1b5e5186ad6f849874bb27cb5aeef18c1510468f1b6b10b2449477c6cf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom has underperformed the broader market over the past year, while analysts remain strongly optimistic about its future prospects.",
                "category": "company",
                "datetime": 1788871017,
                "headline": "DexCom Stock: Is DXCM Underperforming the Healthcare Sector?"
              },
              {
                "id": 141425987,
                "url": "https://finnhub.io/api/news?id=fc4b38d168fa041f4c4b91cf02111340a73d4f69976f0c9543c6bcb7f7a9bfbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock has delivered a mixed ride for long term holders, with the share price down about 35.1% over five years even as a Discounted Cash Flow (DCF) estimate points to an intrinsic value that sits meaningfully above the current market price. At the same time, broader valuation checks lean cautious and market based multiples look roughly in line with peers rather than clearly cheap. Over the past five years, DexCom shareholders have seen the stock decline about 35.1%, which puts more...",
                "category": "company",
                "datetime": 1788506376,
                "headline": "DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair"
              },
              {
                "id": 141403938,
                "url": "https://finnhub.io/api/news?id=9cbd77af170c95d6ccc8f28fb46ec6d763f649ea850e92a5fadc0fb495458a36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including DexCom (NASDAQ:DXCM) and its peers.",
                "category": "company",
                "datetime": 1788463638,
                "headline": "Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks"
              },
              {
                "id": 141364461,
                "url": "https://finnhub.io/api/news?id=5924938bd1af69a2da1decba43d47368d52414a0182e98dcbb82df881d97656f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788275900,
                "headline": "3 Reasons DXCM Has Explosive Upside Potential"
              }
            ],
            "raw_source": [
              {
                "id": 142467285,
                "url": "https://finnhub.io/api/news?id=3769358d3e460e01434eddeed80016e677e5f20103e739e42ecba5af01f9f33d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/28/Stock-market-chart--representative-image.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "Market Overview\n\n\n\nStocks began their breakout to new all-time highs again, but it remains a highly selective environment. Only the Nasdaq hit a record high, as it finished up 2.06% on the week, and outperformed for the",
                "category": "company",
                "datetime": 1790585196,
                "headline": "The Insider Report: The Leaders Have Taken Off"
              },
              {
                "id": 142460907,
                "url": "https://finnhub.io/api/news?id=a57368bc532321048255f0eef4d920cdc87da7fdf7b0ffdeef89f459559e6839",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "MILAN, September 28, 2026--The Tandem Mobi automated insulin delivery system with Control-IQ+ automated insulin delivery technology is now available in 12 international markets.",
                "category": "company",
                "datetime": 1790578800,
                "headline": "Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets"
              },
              {
                "id": 142460906,
                "url": "https://finnhub.io/api/news?id=d7a5888e163f7e34cadd3d2f283f60b4d3498bf33975189d23da7e00b1acf7e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "MILAN, September 28, 2026--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its \"Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology\" in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28-Oct. 2. The company also announced a partnership to become the official continuous glucose monitor of Team Novo Nordisk.",
                "category": "company",
                "datetime": 1790575200,
                "headline": "Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care"
              },
              {
                "id": 142467762,
                "url": "https://finnhub.io/api/news?id=b6dca09324250ed8938c3bd363d9f85be70e0d34f6d15f85c4c20ae05dfa6950",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1New partnership reinforces Dexcom’s commitment to advancing",
                "category": "company",
                "datetime": 1790565474,
                "headline": "Dexcom Becomes Team Novo Nordisk's Official CGM Partner, Releases Report Citing Three Type 2 Care Challenges Across Eight Countries"
              },
              {
                "id": 142421217,
                "url": "https://finnhub.io/api/news?id=73eb6ea9964792dd56d2fb2b2f2942337fa260c9cdd64aea611f01d6a23dcd60",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
                "category": "company",
                "datetime": 1790336197,
                "headline": "2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds"
              },
              {
                "id": 142389564,
                "url": "https://finnhub.io/api/news?id=ab4f9e99bbbeb3352d6984d2da00ffaa897b44bbcdf67afb376dbf86253e3dd1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom shares have delivered a mixed ride in recent years, and that uneven path raises a simple question for anyone looking at the chart today. Is the current US$87.47 price adequately supported by the cash the business is expected to generate over time? Over the past 5 years the stock has declined 36.0%, which puts the focus squarely on whether the cash flow story still lines up with the share price. The recent move to expand Jereme Sylvain’s remit to Chief Operating Officer as well as...",
                "category": "company",
                "datetime": 1790295609,
                "headline": "DexCom (DXCM) Stock Looks Cheap Based On Future Cash Flow"
              },
              {
                "id": 142370918,
                "url": "https://finnhub.io/api/news?id=7e80c34757dfb5e8e97506f9fb195de5bb917984d87162696be91d6a79a644bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (DXCM) just reshuffled its leadership team, with longtime finance chief Jereme Sylvain stepping into a combined EVP and Chief Operating Officer role that now includes responsibility for global operations and quality. Recent boardroom moves at DexCom have arrived at a time when the 90-day share price return of 27.79% and year-to-date gain of 31.85% point to building momentum. However, the 1-year total shareholder return of 29.97% contrasts with a weaker 3-year record and a deeper 5-year...",
                "category": "company",
                "datetime": 1790224168,
                "headline": "Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?"
              },
              {
                "id": 142366064,
                "url": "https://finnhub.io/api/news?id=a735547d4009b8a6a2ff1c97ea29d07de4f3eb90a08524cdb3ae4c0418045a0a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to governance. The leadership shift, including Sylvain's promotion and Boehnlein's board appointment, deserves weighing alongside DexCom's broader fundamentals and risks. Take a look at 3 other big wins we have identified for DexCom. For readers looking to...",
                "category": "company",
                "datetime": 1790201622,
                "headline": "DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer"
              },
              {
                "id": 142364255,
                "url": "https://finnhub.io/api/news?id=895685be22cd87859303846feda7f64760fc0297ce940d33c824aa0414d154ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.",
                "category": "company",
                "datetime": 1790101500,
                "headline": "Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring"
              },
              {
                "id": 142310755,
                "url": "https://finnhub.io/api/news?id=92eed5103bf0ea374a58ca1e7b576333d065b92ab5af27bca906a641b348f8df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.",
                "category": "company",
                "datetime": 1789988065,
                "headline": "2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down"
              },
              {
                "id": 142307394,
                "url": "https://finnhub.io/api/news?id=7bc174f162091d9036397952184db2de41e5e61e125e11ffded05e0f7cc529bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- \"Wearable Biosensors Market - Global Forecast to 2036\" has been added to ResearchAndMarkets.com's offering.According to the research report, the global wearable biosensors market is projected to reach USD 105.5 billion by 2036 from USD 35.5 billion in 2026, growing at a CAGR of 12.5% during the forecast period (2026-2036). The growth of this market is primarily driven by the escalating demand for continuous health monitoring, the rising prevalence of ch",
                "category": "company",
                "datetime": 1789981440,
                "headline": "Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players"
              },
              {
                "id": 142271637,
                "url": "https://finnhub.io/api/news?id=730ce01b8e45e7d0d0cea2dc2e8151ad596a5f7f5e6060130ea168cdd26aa9e1",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "Truist Securities  analyst Richard Newitter   maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $93 to $102.",
                "category": "company",
                "datetime": 1789735782,
                "headline": "Truist Securities Maintains Buy on DexCom, Raises Price Target to $102"
              },
              {
                "id": 142271638,
                "url": "https://finnhub.io/api/news?id=6ee129161211c25318ac879637ad4a449a31809f2b9f29daed78db95040e7dfb",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "TD Cowen  analyst Joshua Jennings   reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $95 price target.",
                "category": "company",
                "datetime": 1789728853,
                "headline": "TD Cowen Reiterates Buy on DexCom, Maintains $95 Price Target"
              },
              {
                "id": 142253117,
                "url": "https://finnhub.io/api/news?id=e11028fe46d2f48c6ef48e72b060b54606b0ee35c8994be445e30b364af77ec5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1789727560,
                "headline": "2 Unpopular Stocks That Should Get More Attention and 1 We Question"
              },
              {
                "id": 142197315,
                "url": "https://finnhub.io/api/news?id=f9b690efa346ffbc94d60bb451c6e3888d4bef728ac1204db8a94505ecd775e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.",
                "category": "company",
                "datetime": 1789529598,
                "headline": "Dexcom gives CFO Jereme Sylvain expanded role"
              },
              {
                "id": 142141666,
                "url": "https://finnhub.io/api/news?id=e1cab6faa1b4651b320e6f31733d8419da2548b0a2da7354abd2eaf3d116e8db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, September 14, 2026--Dexcom Promotes Jereme Sylvain to Chief Operating Officer",
                "category": "company",
                "datetime": 1789417800,
                "headline": "Dexcom Promotes Jereme Sylvain to Chief Operating Officer"
              },
              {
                "id": 142141667,
                "url": "https://finnhub.io/api/news?id=c8407fc472f5b8188b750160e88317d29915f29a69289864ca15585955b9537b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DXCM's strong growth, G7 15 Day adoption and CONNECT trial could expand its CGM market opportunity despite reimbursement and competition risks.",
                "category": "company",
                "datetime": 1789411440,
                "headline": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now"
              },
              {
                "id": 142066269,
                "url": "https://finnhub.io/api/news?id=a9b86a2669b0dee4fa3b7a2d1d65e1fb21112612dcc3ec4f51125f9f2cd786c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, September 10, 2026--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026.",
                "category": "company",
                "datetime": 1789071300,
                "headline": "Dexcom Appoints Glenn Boehnlein to Board of Directors"
              },
              {
                "id": 142061722,
                "url": "https://finnhub.io/api/news?id=1b09565d259ac9bfe618da32adb94625e41d949d1b28c9c53714134c2294b0d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits at high returns.",
                "category": "company",
                "datetime": 1789053664,
                "headline": "3 Quality Compounders with Impressive Fundamentals"
              },
              {
                "id": 142025511,
                "url": "https://finnhub.io/api/news?id=5e26d4769528832e8d6c467dd3c154dedeb94018b2b6266fcf8edaa9128328e5",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DXCM",
                "summary": "DexCom, Inc. (DXCM) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsJereme Sylvain - Executive VP, CFO &...",
                "category": "company",
                "datetime": 1788952625,
                "headline": "DexCom, Inc. (DXCM) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141953963,
                "url": "https://finnhub.io/api/news?id=40add1b5e5186ad6f849874bb27cb5aeef18c1510468f1b6b10b2449477c6cf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom has underperformed the broader market over the past year, while analysts remain strongly optimistic about its future prospects.",
                "category": "company",
                "datetime": 1788871017,
                "headline": "DexCom Stock: Is DXCM Underperforming the Healthcare Sector?"
              },
              {
                "id": 141425987,
                "url": "https://finnhub.io/api/news?id=fc4b38d168fa041f4c4b91cf02111340a73d4f69976f0c9543c6bcb7f7a9bfbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock has delivered a mixed ride for long term holders, with the share price down about 35.1% over five years even as a Discounted Cash Flow (DCF) estimate points to an intrinsic value that sits meaningfully above the current market price. At the same time, broader valuation checks lean cautious and market based multiples look roughly in line with peers rather than clearly cheap. Over the past five years, DexCom shareholders have seen the stock decline about 35.1%, which puts more...",
                "category": "company",
                "datetime": 1788506376,
                "headline": "DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair"
              },
              {
                "id": 141403938,
                "url": "https://finnhub.io/api/news?id=9cbd77af170c95d6ccc8f28fb46ec6d763f649ea850e92a5fadc0fb495458a36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including DexCom (NASDAQ:DXCM) and its peers.",
                "category": "company",
                "datetime": 1788463638,
                "headline": "Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks"
              },
              {
                "id": 141396046,
                "url": "https://finnhub.io/api/news?id=90fc089244dc8485ed1bae6ed814953047aba3ac1c4095ec57995ccba0e89f82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Reviewing prior stock picks is how investors turn experience into valuable feedback.  A recommendation is only a thesis until the market tests it.  Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions.",
                "category": "company",
                "datetime": 1788414660,
                "headline": "Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services"
              },
              {
                "id": 141364461,
                "url": "https://finnhub.io/api/news?id=5924938bd1af69a2da1decba43d47368d52414a0182e98dcbb82df881d97656f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788275900,
                "headline": "3 Reasons DXCM Has Explosive Upside Potential"
              },
              {
                "id": 141364462,
                "url": "https://finnhub.io/api/news?id=13c97255d370689eb9f90297a0211b08089b8745c33c05d2de88651317780fa0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, September 01, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.",
                "category": "company",
                "datetime": 1788269400,
                "headline": "Dexcom Announces Upcoming Conference Presentation"
              },
              {
                "id": 141364463,
                "url": "https://finnhub.io/api/news?id=c9b6fc6bffb3e3d7e0e29642779ed31313c55591b3bc61dab67540e17181933a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1788183001,
                "headline": "Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 141352563,
                "url": "https://finnhub.io/api/news?id=62cc47117b3b9089b94543a3b43428caf46231c1d5d9006a1fe7d5275c3d64c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Great stock picks are just the start to building a portfolio that can shelter you through whatever the market brings.",
                "category": "company",
                "datetime": 1788100202,
                "headline": "Everything I Learned from My Hot Chart Summer, and How My 21 Stocks Picks Have Performed."
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 28,
            "discarded_article_count": 20
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.4,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.5,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日4日)；站上MA50；升放量(近10日3日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 4138743.3333333335,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 4802870,
              "avg_vol_20": 4008620,
              "avg_vol_30": 4138743.3333333335,
              "range_pct_10": 0.08225657591139819,
              "range_pct_20": 0.11594370096908163,
              "range_pct_30": 0.1188278726349792,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.1604657774541869,
              "dist_to_20d_high": 0.06129521334199693,
              "down_shrink_days": 4,
              "breakout_level_20d": 92.34,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.6922330097087376
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.555376095985233,
              "turnoverUsdM": 289.54292488,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DXCM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 82.25,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.1,
            "take_profit_price": 91.0989,
            "target_multiplier": 1.9,
            "technical_strength": 1.58,
            "take_profit_percent": 5.1
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.110752191970466,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 2.215,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.56
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -34.67
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.056
    },
    "kdj": {
      "d": 60.74,
      "j": 29.87,
      "k": 50.45,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "強資金流入",
      "score": 10,
      "value": 70.01
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 69030466,
      "recentSlope": 2043306.6,
      "previousSlope": -766050
    },
    "rsi": 58.54,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 83.7669,
      "position": "SAR喺價下",
      "distancePct": 3.36,
      "previousTrend": "上升"
    },
    "ma50": 85.3324,
    "macd": {
      "macd": 0.3628267832568923,
      "trend": "中性偏多",
      "signal": 0.591050493545111,
      "histogram": -0.22822371028821864
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 87.3855,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.83,
      "score": 4,
      "avgVolume": 4048303,
      "currentVolume": 3340366
    },
    "derived": {
      "ma20": 87.37,
      "ma50": 85.3324,
      "prevClose": 86.62,
      "avgVolume10": 4882817,
      "avgVolume20": 4048303,
      "changePercent": 0.07,
      "avgVolumeForScore": 4048303
    },
    "ma_cross": {
      "ma20": 87.37,
      "ma50": 85.3324,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 87.577,
      "prevMa50": 85.1318,
      "spreadPct": 2.39,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 82.8736,
      "upper": 91.8664,
      "position": "中間"
    },
    "rsi_short": 11.97,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.83
    }
  }
}

{
  "close": 86.68,
  "volume": 3340366,
  "changePercent": 0.07
}